TipRanks
Tandem Diabetes Care (DE:TD5A)
FRANKFURT:TD5A
Germany Market
TD5A
Tandem Diabetes Care
RESEARCH TOOLSreports

Tandem Diabetes Care (TD5A) Stock News & Sentiment

3 Followers
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
Premium
Ratings
Tandem Diabetes Care: Buy Rating Reaffirmed on Transformation Momentum and Innovation Catalysts; $40 Price Target Maintained
2M ago
TNDM
Tandem Diabetes Care Earnings Call Highlights Growth
Premium
Company Announcements
Tandem Diabetes Care Earnings Call Highlights Growth
2M ago
TNDM
Analyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
Premium
Ratings
Analyst Reiterates Buy on Tandem, Citing Building Momentum Ahead of Mobi Tubeless Launch and Improving Margins
2M ago
TNDM
TNDM Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
TNDM Earnings this Week: How Will it Perform?
2M ago
TNDM
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
Premium
Ratings
Tandem Diabetes: Neutral Stance Maintained as Mobi Tubeless Opportunity Balances Execution Risks; $25 Price Target Unchanged
4M ago
TNDM
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
Premium
Company Announcements
Tandem Diabetes Shareholders Approve Governance and Incentive Changes
5M ago
8K
TNDM
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
Premium
Company Announcements
Tandem Diabetes Care Rides Record Quarter, Reaffirms Outlook
5M ago
TNDM
More DE:TD5A News >

TD5A News on the Web

Barclays Keeps Their Hold Rating on Tandem Diabetes Care (TNDM)
TipRanks News
Neutral
Tandem Diabetes Care (TNDM) Receives a Buy from RBC Capital
TipRanks News
Bullish
Analysts Are Bullish on These Healthcare Stocks: Mediwound (MDWD), BridgeBio Pharma (BBIO)
TipRanks News
Bullish
After a sell-off, this medical device stock looks like a gift for patient investors
CNBC
Neutral
Tandem Diabetes Care Earnings Call Highlights Growth
TipRanks News
Bullish
Tandem Diabetes Care (TNDM) Gets a Hold from Goldman Sachs
TipRanks News
Neutral
Tandem Diabetes price target lowered to $20 from $24 at Mizuho
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Boston Scientific (BSX)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DE:TD5A
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:TD5A’s Media Buzz Sentiment?
4 articles about DE:TD5A were published this week. In an average week, 1.75 articles are published.
    What is DE:TD5A’s weekly average amount of articles?
    In an average week, 1.75 articles about DE:TD5A are published.
      What is DE:TD5A’s News Sentiment?
      100% of articles about DE:TD5A were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        GKOSGlaukos
        OVIDOvid Therapeutics
        ABTAbbott Laboratories
        IQVIQVIA Holdings
        Showing the stocks with the most bullish news sentiment over the past week